Boston Scientific CorporationBSXNYSE
LOADING
|||
EV to Sales: Premium Valuation
Trending higher, above historical average, modest growth trend.
Left:
||||
Enterprise value to sales ratio
Latest
8.49
↑ 48% above average
Average (9y)
5.75
Historical baseline
Range
High:8.49
Low:3.99
CAGR
+8.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 8.49 | +30.5% |
| 2023 | 6.50 | +10.7% |
| 2022 | 5.88 | +2.8% |
| 2021 | 5.72 | -3.5% |
| 2020 | 5.93 | -12.8% |
| 2019 | 6.80 | +19.9% |
| 2018 | 5.67 | +30.3% |
| 2017 | 4.35 | +5.3% |
| 2016 | 4.13 | +3.5% |
| 2015 | 3.99 | - |